#Peter Doshi

[informationglob]

Jaipur Music Stage welcomes its visitors at Hotel Clarks Amer

Jaipur Music Stage welcomes its visitors at Hotel Clarks Amer

The Jaipur Literature Festival 2023 is all set to bring a range of exhilarating performers to the Jaipur Music Stage, which will run parallel to the festival. Infusing the audience with a melodic exuberance at the literary extravaganza, the Jaipur Music Stage will be a 3-day long program, set to run from 19th- 21st January 2023, featuring a range of celebrated artistes from all around the…

[100hands]

Thanks to SwissNex and the Swiss Consulate, it was our good fortune to have had some time with Mr. Peter Zumthor, the great Swiss architect here in Bangalore. As part of his visit he saw BV Doshi’s masterwork, the Indian Institute of Management Bangalore, the Bhoga Nandeeshwara Temple, Bangalore International Centre and MAP.

I also had the opportunity to engage Mr. Zumthor in an hour long conversation about his work and realizations. This event felt like the opening night of a big Bollywood blockbuster. Mr. Zumthor’s work and writings find a particular resonance in India. His ideas of work predicated on place, memory, materiality and presence, a word he uses often, make direct connections to our own traditional buildings and the work of masters like Le Corbusier, Louis Kahn, Charles Correa and BV Doshi.

I haven’t visited any of Mr. Zumthor’s buildings, but from his drawings and ethereal photographs often by Hélène Binet, they seem archaic, primordial – evoking the sense of refuge within geological formations. His work and methods seem anachronistic – reminding us of the rigour and care architecture demands and the single minded pursuit of emotionally charged space. Mr. Zumthor’s work attempts to discover ‘deep structure’, drawing out a shared recapitulation of ancient memory.

[thedepartmentofdiscoveries]

Jiang-Shi from the 1985 Hong Kong Action Comedy "Mr. Vampire" directed by Ricky Lau.

"If you meet a vampire, don't breathe." This is the sage advice that Master Kau, the Taoist priest played by Lam Ching-ying, gives to his bumbling apprentices, Man-choi (Ricky Hui) and Chau-sang (Chin Siu-ho), in the 1985 Hong Kong action comedy "Mr. Vampire."

Forget everything you know about bloodsuckers; the undead specimens in "Mr. Vampire" are breath-suckers. They have a very deliberate way of hopping with their arms stretched out in front of them, legs also stiff and straight from rigor mortis. In Chinese, these zombie-like revenants are known as the jiangshi; in Japanese, it's kyonshi, while in English, they're sometimes referred to as "Chinese hopping vampires."

Stirred up by the disinterment of a parent who was buried with bad feng shui, the jiangshi of "Mr. Vampire" are a comedic answer to the unsettled ghosts of subsequent Asian horror films like "Ringu" and "The Eye." They're the reanimated corpses of people who died "with grievances or stress," suffocating to death yet holding one last breath in their throat, which enables them to come back and prolong their existence by sinking their sharp blue nails into humans and sucking the breath out of them.

At a certain point, the tropes of Western vampire films lose their power and become cliches we've all seen done to death on celluloid. If you enjoyed the Asian zom-com flavor of "One Cut of the Dead" and are looking for something a little more off the beaten film path, "Mr. Vampire" draws from Chinese folklore to offer a fresh, hilarious take on vampires, one that jumpstarted a whole franchise and jiangshi genre, complete with four sequels and an 8-bit Nintendo video game ("Reigen Doushi," which became "Phantom Fighter" in the U.S.)

Directed by Ricky Lau, "Mr. Vampire" found a way to uproot the undead from European folklore and Eurocentric cinema and make them work within the context of Eastern religions and Asian cultures. How do you make bloodsuckers scary and/or funny for audiences with a background in reincarnation traditions, ancestor worship, and hungry ghosts? For a Buddhist or Taoist, death and rebirth (or "undeath") would be part of a natural cycle, and for a Shintoist, a vampire might elicit sympathy as a tragic figure, trapped between worlds like the spirit of a family member who couldn't find their way back down the lantern river to heaven.

This goes back to Richard Matheson's idea of vampires not fearing crosses if they weren't Christian in life. Drawing from legends known and recognized by other names across East Asia, "Mr. Vampire" and its jiangshi enjoyed further regional popularity outside Hong Kong. Taiwan quickly followed suit with its own kid-friendly hopping vampire film "Hello Dracula," and Japan embraced both movies, making "Mr. Vampire" board games and televising "Hello Dracula" as a popular miniseries, "Yugen Doshi Kyonshizu."

In his essay, "Enter the Dracula: The Silent Screams and Cultural Crossroads of Japanese and Hong Kong Cinema" (collected in the book "Dracula, Vampires, and Other Undead Forms," edited by Caroline Joan Picart and John Edgar Browning), Wayne Stein wrote of how kids in Asia "found themselves with a new likeness to imitate by copying the hopping movements of these zany vampires," the jiangshi. I can confirm that my own spouse and her classmates were among those kids. To them, the hopping vampires of the 1980s were as much fun to emulate as the dancing zombies of Michael Jackson's "Thriller" music video.

To appreciate the full significance of "Mr. Vampire" and its unprecedented local popularity as a homegrown Asian vampire movie, it's helpful to understand that it was not the first eastward voyage of the Demeter, so to speak. An early attempt at combining vampires with martial arts came in 1974 with "The Legend of the 7 Golden Vampires," which marked Peter Cushing's final outing as a vampire hunter (and now, guest lecturer in China) Van Helsing in Hammer Horror's Dracula series. The film was an international co-production between Hammer and Hong Kong's biggest production company, Shaw Brothers Studio, which was ready to capitalize on the kung fu success of the late Bruce Lee, whose posthumous hit, "Enter the Dragon," had overtaken theaters the year before.

"The Legend of the 7 Golden Vampires" proved to be a financial failure, perhaps in part because — beneath the foreign-market masquerade — its inner workings were still Western and imperialist. At the time, Hong Kong was a crown colony, and the film's opening scene sees Kah (Chan Shen), the Chinese "High Priest of the 7 Golden Vampires," kneel before the very British Dracula (John Forbes-Robertson), asking for his help back home. Dracula tells his "minion" that he doesn't roll like that; he then proceeds to spell out in no uncertain terms how he plans to appropriate Kah's culture. "I need your vile image," he says. "I will take on your mantle, your appearance."

Before the title card comes up, Dracula turns Chinese, using Kah as his host body, cackling at how "beneath the image, the immortal power of Count Dracula" still lurks. "The Legend of the 7 Golden Vampires" wore the cape of a Hong Kong vampire film, but "Mr. Vampire" tossed the cape in favor of authentic Chinese burial clothes.

"Mr. Vampire" imparts useful skills for what to do when you're beset by hopping vampires. Forget holy water; you need sticky rice to deal with these things. Just make sure local merchants aren't cheating you by mixing in long-grain rice with the sticky rice. That will render it less effective in preventing the "vampirification" of friends who are wounded and poisoned in the acrobatic scuffle with hopping vampires.

One surefire method of stopping a hopping vampire is to pin a Taoist talisman to its forehead. They can even be controlled and sicced on other vampires this way. Be careful not to sneeze, as this could blow the talisman off, and then you'll be s*** out of luck, as the French say.

If you yourself begin turning into a stiff-legged hopping vampire, keep active! Dance it out the way you would if you suspected you had restless leg syndrome but had never been officially diagnosed.

Mirrors, as we see in "Mr. Vampire," do repel the jiangshi, more forcefully than their Western counterparts even, so you've got that going for you, at least, if you've been weaned on the rules of Western vampire films. It is possible to plug up the nostrils of hopping vampires so they lose the scent of your breathing.

A separate peril of places in the countryside overrun by hopping vampires is the possibility of ghosts with the face of "Pauline" Wong Siu-fung enchanting you and leaving you with "love bites." As vampire attacks mount, the last resort is to try warding them off with raw poultry, saying, "Big brother, eat the chicken!" Good luck, and remember the most important rule of vampire hunting: just have fun with it.

Read More: https://www.slashfilm.com/976576/year-of-the-vampire-hold-your-breath-for-the-hopping-undead-in-mr-vampire/

[palmiz]

"PETER DOSHI ALL'FDA: "INSERITE LA MORTE IMPROVVISA NEI BUGIARDINI" - Corto tg 14/06/2023"

[kramlabs]

What happens when only 16% of flu patients have the flu?

Here is how serious propaganda works: Over a a long period of time, you build up a gigantic lie. You keep reinforcing it.

You have major money behind you, as well as institutions of government, and corporations. You forge that lie, and you keep repeating it over and over.

Finally, and this is the payoff, you reach a point where a refutation of the lie would seem, to most people, like a piece of incomprehensible insanity, like gibberish.

Therefore, the refutation of the lie would tend to be invisible. It would sink like a small stone, leaving no trace.

After writing about fake vaccine science since 1988, I thought I’d seen it all:

Wild falsehoods about vaccines creating immunity; suppressed information about toxic ingredients in the shots and their devastating health effects; the absence of proper controlled studies proving vaccines are safe and effective.

But Peter Doshi, PhD, writing in the online BMJ (British Medical Journal), reveals a new monstrosity. It’s all based on the revelation that most “flu” is not the flu.

Follow this closely. If you blink, you might miss it.

You see, as Doshi states, every year, hundreds of thousands of respiratory samples are taken from flu patients in the US and tested in labs. Here is the kicker: only a small percentage of these samples show the presence of a flu virus.

This means: most of the people in America who are diagnosed by doctors with the flu have no flu virus in their bodies.

SO THEY DON’T HAVE THE FLU.

Therefore, even if you (falsely) assume the flu vaccine is useful and safe, it couldn’t possibly prevent all those “flu cases” that aren’t flu cases. The vaccine couldn’t possibly work.

The vaccine isn’t designed to prevent fake flu, unless pigs can fly.

Here’s the exact quote from Doshi’s BMJ review, “ Influenza: marketing vaccines by marketing disease” (BMJ 2013; 346:f3037):

“…few people realize that even the ideal influenza vaccine, matched perfectly to circulating strains of wild influenza and capable of stopping all influenza viruses, can only deal with a small part of the ‘flu’ problem…Every year, hundreds of thousands of respiratory specimens are tested across the US. Of those tested, on average 16% are found to be influenza positive….It’s no wonder so many people feel that ‘flu shots’ don’t work: for most flus, they can’t.”

Because most diagnosed cases of the flu aren’t the flu.

So even if you’re a true believer in mainstream vaccine theory, you’re on the short end of the stick here. They’re conning your socks off.

A patient walks into a doctor’s office. He’s sick. He’s coughing. He has a fever. His muscles ache. The doctor says, “You have the flu. Did you get your flu shot this year?”

“No,” the patient says.

The doctor gives him a stern look. “Well, you should have. See? You’re sick now. The vaccine would have prevented that.”

Wrong.

Again, even by conventional standards, the odds are very high the vaccine would have made no difference at all. Because the odds are very high this patient doesn’t have an influenza virus.

Overwhelmingly, doctors diagnose the flu with a casual eyeball glance. The patient has a familiar cluster of symptoms? It’s flu season? Okay, it’s the flu. Period.

With an ongoing blizzard of psyop-marketing, people accept “flu” and react emotionally to the propaganda about it.

In 2009, as the heralded Level 6 global pandemic, Swine Flu, was proving to be a bust and a trickle, Sharyl Attkisson (CBS News) discovered that the CDC had stopped counting the number of Swine Flu cases in America.

The CDC had stopped counting, because their tests on diagnosed flu patients showed so many who didn’t have the flu virus, who didn’t have the flu at all.

Atkisson’s reporting was explosive. It was threatening to expose the whole flu psyop. What would happen if it became common knowledge that most people diagnosed with the flu don’t have the flu? What would happened to the campaigns to get people to take flu vaccines?

Attkisson was muzzled. And the CDC doubled down and suddenly claimed there were undoubtedly TEN MILLION cases of Swine Flu in the US. This, after only several thousand cases had been reported.

This is on the order of saying a dry creek-bed in the woods is actually the Mississippi River.

Twisting words and numbers and painting false pictures is the CDC’s job.

Do you have an advanced degree, and are you a liar and a criminal? The CDC needs you.

:::

[darkmaga-retard]

'Co-breaking' with Jason Olbourne of World Series News Underground TV

Raphael Lataster, PhD

Sep 18, 2024

Long story short

This is pretty big. Estimates of COVID-19 vaccine effectiveness derived from NSW government COVID-19 reports are unreliable up to early 2022, with people who received the jab being lumped in together with the unvaccinated. Different definitions were later used, with no great recognition of the potential harm done regarding the former, so we sent off an FOI request to see if there really was a difference. The NSW government has decided not to fully answer our request, either because they don’t have the data ‘anymore’ or they have the data but don’t want to share.

Long story long

Aware of my medical journal articles, published alongside the likes of BMJ editor Peter Doshi, indicating that counting window issues (revolving around delays [someone is only considered vaccinated after some arbitrary time], biases [vaccinated and unvaccinated groups are treated differently], and misclassifications [people who took the vaccine are called unvaccinated]) in both the clinical trials and observational studies meant that the efficacy/effectiveness and safety of the COVID-19 vaccines have likely been highly exaggerated (even to the extent that they may be negatively effective), Jason Olbourne of World Series News Underground TV reached out with an intriguing proposition. We ought to team up and find out if the government of New South Wales, Australia’s most populous state (and one of the most tyrannical during the pandemic), was also manipulating the data in this way. For example, were some of the ‘unvaccinated’ who died from COVID-19 actually people that took the jab? And, why were there COVID-19 deaths in the unjabbed in late 2022, but no hospitalisations?

[sutrala]

(NaturalNews) The U.S. Food and Drug Administration (FDA) encourages staffers departing for pharmaceutical industry jobs that they can work behind the scenes to...

[poligrafoserio]

Os estudos observacionais sobre a eficácia da vacina contra a COVID estão repletos de preconceitos/Não contar os casos 14 dias após a dose 2 é um problema

Finalmente tive a oportunidade de ler este artigo de Peter Doshi , professor e pesquisador da Universidade de Maryland. É bastante inteligente e ensina princípios de epidemiologia. Vou resumir uma parte do artigo e, em capítulos futuros, aprofundarei seus outros pontos.

Ponto nº 1: muitos estudos observacionais sobre a eficácia da vacina excluem casos que ocorreram dentro de 14 dias após a dose 2. Em outras palavras, qualquer pessoa que contraia COVID 36 dias após a primeira dose (as doses têm 21 dias de intervalo para a Pfizer) não conta contra o vacina. Isso ocorre porque - continua o argumento - leva tempo para a vacina fazer efeito, então você não pode usar os primeiros dias contra ela.

Claro que é um argumento bobo. Um produto médico é dono de tudo o que acontece depois que você começa a tomá-lo. É claro que se as vacinas demorassem um milhão de anos a fazer efeito, seriam inúteis. Se demorarem um ano inteiro e todos ficarem cobiçosos nesse ano, seriam inúteis. Omitir estes casos é irresponsável, mas continua.

Mas o que Doshi quer dizer é que isso pode fazer com que um produto inativo — algo totalmente inútil — pareça funcionar. Ele fornece esse experimento mental.

No experimento, diz ele, e se compararmos o braço de controle do estudo da Pfizer com um braço imaginário da vacina. E para o experimento mental, presuma que a vacina é inútil. Como mostra a tabela acima, ambos os grupos têm números idênticos de casos de covid – exatamente o que seria de esperar de uma vacina inútil. Uma análise direta não mostra nenhum benefício (penúltima linha)

Mas no “estudo observacional de vacina fictícia” os casos são excluídos durante 36 dias. Quando isso é feito, a vacina inútil parece reduzir as infecções em 48%!!

Doshi destaca em seu artigo que a solução é subtrair a taxa de infecção de 36 dias do braço de controle observacional. Infelizmente, a maioria das investigações não faz isso.

Este é um dos vários preconceitos discutidos por Doshi e que prejudica a literatura sobre vacinas. Mais na próxima vez. Se inscrever.

Artigo original:

[mightyflamethrower]

I have been highly critical of the British Medical Journal, with good reason. It publishes some good research, and way too much political tripe. 

This story falls more into the former category than the latter. 

Anybody who has taken a serious interest in the relationship between the Food and Drug Administration and the pharmaceutical and medical device industries is struck by an obvious fact: the revolving door between the regulators and the regulated is utterly corrupt. 

The phenomenon is called regulatory capture. When this happens, as it often does, the regulators see their own interests as more aligned with the industry than with the general public. It happens much more often than you would think or hope. I once heard a story from a friend who worked on Capitol Hill about a Senate researcher who helped write tax laws. 

He put in a provision that was so complicated that nobody could make heads or tails of it, then went into business as a consultant who explained what it meant to people. 

He made bank. 

Regulatory capture is similar to this. The regulators become "experts" on how the system works, making themselves extremely valuable to the regulated. No industry would ignore the value of having especially good relations with the people on the other side of a negotiating table. 

It's a match made in heaven, except for you and me. We are the rats experimented upon. 

There are, of course, ethics rules that are supposed to prevent conflicts of interest, and when regulators are working in government they are not allowed to invest in companies they regulate. 

The US Food and Drug Administration says that it takes conflicts of interest seriously. But financial entanglements with the drug industry are common among its leaders. Peter Doshi reports At his public confirmation hearing in late 2021, Robert Califf, President Biden’s nominee to lead the US Food and Drug Administration (FDA), faced pointed questions about his financial relationships with industry. Bernie Sanders, the senator from Vermont, asked, “At a time when the American people are outraged by the high cost of prescription drugs, deeply disturbed about what happened with Purdue and Oxycontin, what kind of comfort can you give to the American people when you have been so closely tied to the pharmaceutical industry yourself?” He added, “How can the American people feel comfortable you’re going to stand up to this powerful special interest?” Califf responded: “Senator Sanders, I have a history of doing that. But I’d also point out that this administration has the most stringent ethics pledge in the history of administrations.” Califf did not earn Sanders’s vote, but he got the job. With it, the incoming FDA commissioner committed to sell his pharmaceutical stocks and sever his financial relationships with biotech companies such as Alphabet owned Verily Life Sciences, which paid Califf $2.7m as a senior adviser, according to his federal disclosure (see supplementary files on bmj.com).

Of course, when there is a revolving door, this is something of a scam. While it is true that having people with experience in the medical industries can be valuable for government regulators--they know the business, after all--the opposite is true as well.

And, of course, the friendlier the regulator is to an industry, the more valuable they become to those within it. 

The year 2022 marked Califf’s second time leading the FDA, having previously served during the Obama administration’s final year. It was therefore his second time terminating a host of ties with the companies that the agency is meant to regulate, and his second time signing an ethics pledge. The Trump administration, too, required that appointees sign an ethics pledge, committing not to lobby the agencies for five years after public service. But the requirement was rescinded on 19 January 2020, Trump’s last full day in office. In addition, the ban only applied to lobbying activities, not employment in general, and within three months of vacating the FDA’s top job, Scott Gottlieb, Trump’s first nominee who led the agency from 2017 to 2019, was nominated to Pfizer’s board of directors, subsequently gaining enormous public visibility through regular media appearances as a covid expert commentator. (While a medical student, Gottlieb interned at The BMJ as a Clegg scholar; he subsequently penned a number of BMJ news articles.) The revolving door between the FDA and industry surprises few anymore, despite the widely acknowledged potential it has for undermining public trust in government. And stories about FDA commissioners’ heavy ties to industry have become commonplace: nine of the FDA’s past 10 commissioners went on to work for the drug industry or serve on the board of directors of a drug company.

Advertisement

This happens all the time, and bureaucrats like it that way. And, frankly, so do many lawmakers who can do the same sort of thing--build up good relationships with companies and retire later with a windfall. 

In political science we call this the iron triangle, where the regulators, the industries, and the politicians all share a common interest that diverges from the public's.

This is how you get unsafe and/or ineffective drugs through the system and how, I suspect, the jabs got out into the wild. Tens of billions of dollars are made based on these sorts of decisions. 

Paxlovid is a great example. It has never been shown to be effective in the least, but the government spent zillions of dollars buying it and promotes the heck out of it as the money rolls into the coffers of Pfizer. It also has a pretty nasty side-effect profile. 

This is how it works, folks. Follow the money.

[alexishectorr]

Tamiflu and Relenza review questions effectiveness against flu

Tamiflu (oseltamivir) and Relenza (zanamivir) are classes of drugs known as neuraminidase inhibitors. Both drugs are thought to prevent and reduce symptoms of flu by stopping the influenza virus from spreading inside the body.

At present, Tamiflu is used to combat flu in patients 2 weeks of age and older whose symptoms have not lasted longer than 2 days. It can be used to prevent flu in patients aged 1 year and older. Relenza is used to tackle flu in patients aged 7 years and older and can be used for flu prevention in those aged 5 years and older.

According to the researchers involved in this latest review, including Dr. Carl Heneghan of the University of Oxford in the UK and Dr. Peter Doshi of the University of Maryland School of Pharmacy in the US, both drugs are stockpiled for use against seasonal and pandemic influenza. For example, the US has spent over $1.3 billion on reserves of influenza antivirals.

This stockpiling has been based on international and national recommendations from bodies such as the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC). But what are their recommendations based on?

[clemsbiggestfan]

Literally just a list of every book I've read this year, ranked.

A Heart That Works - Rob Delaney

Written in Bone - Sue Black

Our Wives Under the Sea - Julia Armfield

The Memory of Animals - Claire Fuller

A Marvellous Light - Freya Marske

The Cockroach - Ian McEwan

Why I'm No Longer Talking To White People About Race - Reni Eddo-Lodge

Notes on an Execution - Danya Kukafa

War Doctor: Surgery on the Front Line - David Nott

It's OK to Be Angry About Capitalism - Bernie Sanders

Taste - Stanley Tucci

Glutton: The Multi-Course Life of a Very Greedy Boy - Ed Gamble

Strong Female Character - Fern Brady

Uncomfortable Conversations With a Black Man - Emmanuel Acho

The Nickel Boys - Colson Whitehead

Sidesplitter - Phil Wang

LOTE - Shola von Reinhold

Vladimir - Julia May Jonas

Lessons in Chemistry - Bonnie Garmus

Patricia Wants to Cuddle - Samantha Allen

Climate Change is Racist - Jeremy Williams

Chlorine - Jade Song

The Transgender Issue - Shon Faye

Le Consentement - Vanessa Springora

Black Klansman - Ron Stallworth

Pageboy - Elliot Page

The Herd - Andrea Bartz

All That Remains - Sue Black

James Acaster's Guide to Quitting Social Media - James Acaster

What Would the Spice Girls Do? - Lauren Bravo

Educated - Tara Westover

The Frighteners - Peter Laws

Gay Bar: Why We Went Out - Jeremy Atherton-Lin

Fix the Systen, Not the Women - Laura Bates

The History Boys - Alan Bennett

Letters of Note: Love - Shaun Usher

The Metamorphosis - Franz Kafka

What a Shame - Abigail Bergstrom

Burnt Sugar - Avni Doshi

Just by Looking at Him - Ryan O'Connell

Devil House - John Darnielle

Poor - Caleb Femi

The Decagon House Murders - Yukito Ayasuji

I'm Afraid of Men - Vivek Shraya

I'm a Fan - Sheena Patel

The Mad Women's Ball - Victoria Mas

Daisy Chains - Lynne Vande Stouwe

Lemons Lemons Lemons Lemons Lemons - Sam Steiner

Confessions of a Funeral Director - Caleb Wilde

Misfits: A Personal Manifesto - Michaela Coel

Insomnia - Marina Benjamin

My Darling from the Lions - Rachel Long

Bluets - Maggie Nelson

Heatwave - Victor Jestin

[iamnaturalnana]

The FDA and Moderna’s Cozy Relationship: How Lax Rules Enable a Revolving Door Culture

Cited as: BMJ 2023;383:p248 Peter Doshi, senior editor pdoshi@bmj.com After holding oversight roles for covid vaccines, two regulators from the US Food and Drug Administration went to work for Moderna. Peter Doshi reports The physician-scientist Doran Fink worked his way up at the Food and Drug Administration, with a focus on the regulation of vaccines. Starting as a clinical reviewer in…

[stuartbramhall]

Experts ‘Astounded’ After FDA Rejects Request to Add Health Risks to COVID Vaccine Labels

By Michael Nevradakis, Ph.D. The U.S. Food and Drug Administration (FDA) had the opportunity to improve COVID-19 vaccine labeling — but according to a team of medical and public health experts, the agency refused to make the changes. In an op-ed published last week in The Hill, Peter Doshi, Ph.D., Linda Wastila, Ph.D., and Kim Witczak wrote that the FDA rejected their petition to make changes to…

[awardsrethinkingthefuture]

Receiving Recognition and Appreciation through Architecture Awards

While working in any profession, it  is important that good work is recognised and appreciated by fellow colleagues or people who are experts in the field. Recognition and appreciation boosts a person’s confidence and makes him/her strive to achieve further goals. More than anything else, the professionals  in a certain field bring about the advancement of the field, contributing with innovative ideas, providing solutions that are relevant to the times we live in. 

Architecture is a field that requires critical thinking of a space and creating spaces for the users that give them comfort. For a field that requires thinking and designing for multiple users, architects and designers might not always feel appreciated and validated for the work that they do. This is the reason why it is important that awards that recognize and appreciate architects and designers across the globe irrespective of their backgrounds are held every year in honour of their work. It is crucial to acknowledge the beneficial effects that well-designed or constructed structures have on the communities in which they are located. Aside from acknowledgment, prizes give architects the chance to promote their work and set a good example for future generations.

There are quite a few awards that recognize architects for their work around the world. In today’s world, one also has to be mindful of the inclusivity and diversity of the profession. While the early 20th century was quite focused on the western world, in today’s world, it is seen that the developing countries have contributed equally to the advancement of the field of architecture and design. Along with different backgrounds, it has also become important to promote equality in the workplace. The role of women in architecture and design has been recognized across the world. “Zaha Hadid has been unswerving in her commitment to modernism. Always inventive, she’s moved away from existing typology, from high tech, and has shifted the geometry of buildings.” Pritzker Prize jury chairman, Lord Rothschild, commented. Zaha Hadid is seen as an inspirational figure for the upcoming generation of women architects who strive to achieve excellence. 

Certain architecture awards ensure that women in architecture are recognised for their exceptional contributions to the area of architecture and design in today's world where global concerns of equality and diversity are also crucial. Women are frequently overlooked, so we still need to highlight their contributions. The Pritzker Prize Executive Director, Martha Thorne, said that these honours "truly push them to the forefront, where they deserve to be." The W awards honour the accomplishments made by women in architecture who have progressed the industry. The upcoming generation of female architects are motivated by this, giving them the confidence to pursue their dreams. The W awards have sections that honour young architects, building and architectural innovators, sustainability, and architects from a variety of backgrounds.

Some of the prestigious architecture awards across the globe include the Pritzker Prize, RIBA medal, AIA gold medal, etc. The most prestigious and important honour that each architect aspires to get is the Pritzker Award, commonly referred to as the Nobel Prize of architecture. Regardless of nationality, race, creed, or ideology, the prize honours the architect's outstanding contribution to the area of architecture. Peter Zumthor, BV Doshi, and Zaha Hadid are just a few of the honorees.

The Royal Institute of British Architects (RIBA) Gold Medal honours an architect or architectural practise for their contribution to the development of world architecture. Through the President's Medal, the RIBA not only recognises the outstanding body of work produced by architects, but also the work of current students and recent graduates. 

Aside from rewarding innovation, architecture awards provide a forum for addressing today's social challenges. Additionally, rather than competing, prizes encourage interaction and cooperation among colleagues in the architectural community. When one architect picks up skills from the other, it is usually a plus and strengthens their individual skill sets.

Rethinking The Future (RTF) will hold the 13th edition of the RTF Architecture, Construction & Design Awards as the awards season gets underway. The Re-Thinking the Future (RTF) platform (www.re-thinkingthefuture.com) showcases the creativity and talent of designers from around the world. The RTF Awards recognise designers working in all scales and fields. A prize, a certificate, as well as the publication of the winning entry on social networking sites and the RTF newsletter may go to the winner of these awards. The fascinating thing is that the designer may have designed a sizable home development or even a cosy sofa. 

Along with architecture, the RTF Awards also honour achievements in a number of other sectors, including interior design, landscape design, construction, and design. To be inclusive and diverse awards, each field has a number of subcategories. Along with recognising a variety of areas, RTF Awards also honour businesses that have promoted inclusion, diversity, and workplace equality.

[craft2eu]

Vitra Design Museum: Diskurs

Vitra Design Museum: Diskurs

Wir alle hängen in der C-Themen-Schleife und es kostet wirklich Energie aus diesem Kreisen um Konsequenzen, Beunruhigung und Furcht heraus zu kommen. Uns allen fehlt das direkte Gespräch mit interessanten Menschen über Gestaltung, Leben und Zukunft, Inspirationen für neues Sehen, Denken und Handeln. Also empfehle  ich heute einen online-Ausflug “ins” Vitra Museum. Dort warten viele Videos,…